Atrium Therapeutics, Inc. Earnings Per Share (Diluted)
Atrium Therapeutics, Inc. (RNA) reported Earnings Per Share (Diluted) of -$1.18 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-13
- Atrium Therapeutics, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$1.18.
- Atrium Therapeutics, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.97.
- Atrium Therapeutics, Inc. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.75.
- Atrium Therapeutics, Inc. earnings per share, diluted for the quarter ending 2025-03-31 was -$0.44.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month |
|---|---|---|
| 2026-06-30 | -$1.18 10-Q · filed 2026-08-13 | -$2.15 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$0.97 10-Q · filed 2026-05-14 | |
| 2025-06-30 | -$0.75 10-Q · filed 2026-08-13 | -$1.19 10-Q · filed 2026-08-13 |
| 2025-03-31 | -$0.44 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |